Wegovy 1.7 MG/0.75 ML pen 0.75ML
Ended Awarded Last action
- Contract number
- SPE2DR26F20WS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,965
Award facts
- Contract value 100% obligated
- $14,965.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $14,965.39 delivery order to AmerisourceBergen Drug Corp for the supply of Wegovy 1.7 mg/0.75 mL pens on January 16, 2026, with a completion date of January 20, 2026. This firm fixed-price contract, which carries no set-aside designation, is being fulfilled from the contractor's place of business in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving critical federal medical procurement needs for military and veteran healthcare systems. The company's extensive portfolio under the DLA Troop Support Medical IDC encompasses a comprehensive range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for Wegovy, a glucagon-like peptide-1 receptor agonist used for weight management, reflects the company's role in supplying specialized medications to support Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F20WS?
SPE2DR26F20WS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26F20WS worth?
The government has obligated $14,965 on SPE2DR26F20WS.
Is contract SPE2DR26F20WS an order under another contract?
Yes. SPE2DR26F20WS is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F20WS competed?
The extent of competition for SPE2DR26F20WS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award